Beam Therapeutics Inc. is a pioneering biotechnology firm based in Cambridge, Massachusetts, focusing on creating precision genetic medicines. The company is at the forefront of developing innovative treatments for serious diseases, including sickle cell disease, beta-thalassemia, severe alpha-1 antitrypsin deficiency, and certain types of leukemia and lymphoma. With a commitment to advancing healthcare through genetic editing, Beam Therapeutics collaborates with industry leaders like Pfizer and Verve Therapeutics to target rare genetic diseases and cardiovascular conditions, showcasing its dedication to transforming patient care.